Navigation Links
Mindray to Exhibit at 2008 European Congress of Radiology Annual Meeting
Date:2/18/2008

New M5 and DC-3 Color Doppler Diagnostic Ultrasound Systems on Display

SHENZHEN, China, Feb. 18 /Xinhua-PRNewswire-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices in China with a rapidly growing international presence, today announced that Mr. Jie Liu, Mindray's executive vice president of international sales and marketing, and Mr. Sheng Ma, Mindray's president of international sales and marketing for ultrasound imaging systems, will attend the 2008 European Congress of Radiology to be held March 7 to 11, in Vienna, Austria.

"Our products continue to receive strong brand loyalty, particularly in European markets and we are delighted to showcase our ultrasound imaging systems at such a prominent international event," said Mr. Xu Hang, Mindray's chairman and co-chief executive officer. "Specifically, we are excited to display the M5 and DC-3 that both hold significant market potential. Our high-quality, competitively priced products are the result of our disciplined investment in R&D and ability to tailor products by price and functionality for markets around the world."

The company will exhibit both its new M5, a portable color Doppler diagnostic ultrasound system released in December 2007, and DC-3, a color Doppler diagnostic ultrasound system which will be launched domestically upon receiving SFDA approval and internationally upon receiving CE Mark, which is expected to occur during the first quarter of 2008.

"The M5 is ideally suited for both new and traditional markets such as radiology and OB/GYN as well as Point-of-Care-Testing ("POCT") centers such as emergency and operating rooms, intensive care units and general practice offices," said Mr. Li Xiting, Mindray's president and co-chief executive officer. "The DC-3 is customized for hospitals and clinics looking to replace B&W diagnostic ultrasound systems."

The company will also display its established DC-6, DC-6E, DP-6600, DP-7700, DP-8800 plus, DP-9900 plus, DP-2200, DP-3300, DP-6600 Vet products in Expo E at booth number 540.

Since 2003, Mindray has exported its diagnostic ultrasound systems to more than 140 countries. These systems are employed in medical fields such as urology, gynecology, obstetrics, abdomen, small parts and cardiology.

About Mindray

Mindray Medical International Limited is a leading developer, manufacturer and marketer of medical devices in China with a significant and growing presence worldwide. Established in 1991, Mindray offers a broad range of products across three primary business segments: patient monitoring devices, diagnostic laboratory instruments, and ultrasound imaging systems. Mindray is headquartered in Shenzhen, China, and has 29 local sales and service offices in China, as well as sales and service offices in Amsterdam, Boston, Istanbul, London, Mexico City, Moscow, Mumbai, Sao Paulo, Seattle, Toronto and Vancouver. For more information, please visit http://www.mindray.com .

Safe Harbor Statement

This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about new product releases and regulatory approvals are forward- looking statements. Readers are cautioned that these forward-looking statements are only predictions and may differ materially from actual results due to a variety of factors. Forward-looking statements involve inherent risks and uncertainties. Information regarding these risks and uncertainties is included in our public documents filed with the Securities and Exchange Commission. For a discussion of some of the risks and important factors that could affect Mindray's actual results and financial condition, see "Risk Factors" in Part I, Item 3D of Mindray's Annual Report on Form 20-F for the fiscal year ended December 31, 2006 and "Operating and Financial Review and Prospects" in Part I, Item 5 of Mindray's Annual Report on Form 20-F for the fiscal year ended December 31, 2006. Mindray does not undertake any obligation to update any forward-looking statement, except as required under applicable law. All information provided in this press release is as of February 18, 2008, and Mindray undertakes no duty to update such information, except as required under applicable law.

For investor and media inquiries please contact:

In China:

Investor Relations

Mindray Medical International Limited

Tel: +86-755-2658-2518

Email: IR@Mindray.com

Justin Knapp

Ogilvy Public Relations Worldwide, Beijing

Tel: +86-10-8520-6556

Email: Justin.Knapp@Ogilvy.com

In the United States:

Jeremy Bridgman

Ogilvy Public Relations Worldwide, New York

Tel: +1-212-880-5363


'/>"/>
SOURCE Mindray Medical International Limited
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Mindray to Attend 2008 CLSA Asia Investors Forum
2. Mindray to Attend 2007 RSNA Conference in Chicago
3. Mindray to Report Third Quarter 2007 Financial Results on November 1, 2007
4. Mindray Selects Actel Low-Power Flash FPGAs for Demanding Medical Equipment Applications
5. Specimens in BODY WORLDS Exhibitions Stem Primarily from German Body Donation Program
6. An Open Letter to 20/20 and the Shareholders of Premier Exhibitions, Inc.
7. Milestone Scientific to Exhibit at the Chicago Dental Societys 143rd Midwinter Meeting
8. On Valentines Day, Abbott Urges Women to Take Heart With Launch of Faces of Heart Disease Exhibit to Raise Heart Health Awareness
9. The Brand Experience Teams With World Vision to Launch Experience: AIDS Multi-Media Exhibit
10. Total Site Solutions to Exhibit at HIMSS Conference
11. The Institute for Plastination Responds to the Bishop of Manchesters Media Blitz, Assertions, and Allegations About BODY WORLDS Anatomical Exhibition Coming to Manchester
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... 2016 , ... The Orthopaedic Research and Education Foundation (OREF) is pleased to ... MD, began his term as president in March, succeeding John J. Callaghan, MD, who ... president-elect. Richard F. Kyle, MD, will serve as chair, corporate development, succeeding Thomas P. ...
(Date:5/31/2016)... ... 31, 2016 , ... Phynd Technologies, Inc. announced recently the signing of three ... and Shore Medical Center – Somers Point, NJ. The new clients range in bed ... the breadth of Phynd’s solution and its interoperability. , Houston Methodist is a leading ...
(Date:5/31/2016)... ... 2016 , ... In a recent interview on The Greenburgh Report radio show ... WVOX (1460 AM), leading medical insurance advocate Adria Goldman Gross discussed several ... money maelstrom.” , During the interview with Mr. Feiner that aired on May ...
(Date:5/31/2016)... Scotch Plains, NJ (PRWEB) , ... May 31, 2016 , ... ... University of Medicine and Dentistry of New Jersey in the class of 1986, where ... family and cosmetic dentistry at his current location in Livingston since 1989. He has ...
(Date:5/31/2016)... ... May 31, 2016 , ... To meet ... to the healthcare industry, The University of Scranton is adding a Certificate in ... to a career in rapidly growing field of healthcare information. , Healthcare ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... GERMANTOWN, Maryland , May 25, 2016 ... bedient dringenden Bedarf zur ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt ... und Entwicklungsvereinbarung mit Therawis Diagnostics GmbH zur Entwicklung ... zu sein. Ein erstes Projekt wird die Entwicklung ...
(Date:5/25/2016)... 2016  Zymo Research Corp. announced today the ... materials that help researchers obtain the most accurate ... The rapid growth of the study of microbiomes ... standard methods to improve the reproducibility and quality ... at every step of the measurement process including ...
(Date:5/25/2016)... YORK , May 25, 2016 ... Market Size, Share, Development, Growth and Demand Forecast to ... Syringe, Insulin Pump and Others)" published by P&S Market ... at $9,998.3 million in 2015, and it is expected ... Based on type, the insulin pump segment is expected ...
Breaking Medicine Technology: